T cells of the body attack and destroy pancreatic Beta cells in

KGMU 2024

Pathology & Genetics

Easy

Appeared in: KGMU 2024

Explanation

Type 1 Diabetes (T1D) is fundamentally an autoimmune disease characterized by the targeted destruction of pancreatic beta cells.
The primary mediators of this destruction are immune cells, specifically T-lymphocytes (T cells).
Autoreactive CD8+ cytotoxic T-lymphocytes directly kill the beta cells, while CD4+ helper T-cells orchestrate the attack by releasing inflammatory cytokines.
This process, known as 'insulitis,' leads to a progressive and absolute deficiency in insulin production.
The presence of autoantibodies against islet antigens (like GAD and IA-2) serves as a key marker for this autoimmune process, even though T-cells are the primary effectors of the damage.

Option B: Type II diabetes is primarily a metabolic disorder characterized by insulin resistance (cells don't respond to insulin properly) and a relative, not absolute, insulin deficiency. It is not caused by a T-cell autoimmune attack on the pancreas.
Option C: Type III diabetes is not a standard clinical classification. It's a term used in research, often to link Alzheimer's disease with insulin resistance in the brain. It does not describe an autoimmune attack on pancreatic beta cells.
Option D: Addison's disease is an autoimmune disorder, but the immune system attacks the adrenal cortex, not the pancreatic beta cells. This leads to a deficiency of cortisol and aldosterone.

Visual 1: Diagram - An illustration of the pancreas with a magnified view of an Islet of Langerhans. One side shows a healthy islet with intact beta cells, while the other side depicts 'insulitis,' with T-lymphocytes infiltrating the islet and destroying the beta cells. This visually explains the core pathology of Type 1 diabetes.
Visual 2: Flowchart - A flowchart showing the progression of Type 1 diabetes, starting from genetic predisposition and environmental triggers, leading to the activation of autoreactive T-cells, beta-cell destruction, absolute insulin deficiency, and finally, clinical symptoms like hyperglycemia.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Pathophysiology of Type 1 Diabetes Mellitus as background academic context rather than a clinical decision trigger.
Understanding that Type 1 diabetes is an autoimmune process explains why treatment requires lifelong insulin replacement, as the body's own insulin factory (the beta cells) has been destroyed and cannot be regenerated.
Nurses play a critical role in educating patients and families about the nature of the disease, emphasizing that it is not caused by lifestyle choices, which helps reduce stigma and improve adherence to treatment.
This knowledge is crucial for monitoring patients, as the absolute lack of insulin makes them susceptible to Diabetic Ketoacidosis (DKA), a life-threatening emergency that requires immediate nursing intervention.

How to Approach the Question

First, identify the key terms in the question stem: 'T cells,' 'attack and destroy,' and 'pancreatic Beta cells.'
Recognize that 'T cells' are a specific component of the immune system, and their destructive action points towards an autoimmune process.
The target, 'pancreatic Beta cells,' is specific. Recall that beta cells are responsible for producing insulin.
Evaluate the options based on this pathophysiology. Ask yourself: Which of these conditions is known to be an autoimmune disease where T-cells destroy insulin-producing cells?
Eliminate options that do not fit this specific mechanism. Type II diabetes is about insulin resistance. Addison's disease affects the adrenal glands. Type III is not a standard diagnosis.
Conclude that Type I diabetes is the only option that matches the described T-cell mediated destruction of pancreatic beta cells.

Concept Tested & Keywords

Q4tJO2jngsGnbkBbrG1Za6